Natural history of gastrinoma: Lessons from the past

Italian Journal of Gastroenterology and Hepatology

Volumn 31, Issue 7 SUPPL. 2, 1999, Pages

  Mignon, M ^a   Cadiot, G ^b  

^a BICHAT HOSPITAL   (France)

^b Bichat Claude Bernard Hospital ^*

Author keywords

Gastrinoma; MEN 1; Natural history; Prognosis

Indexed keywords

ADULT; BONE METASTASIS; CANCER MORTALITY; CONFERENCE PAPER; CUSHING SYNDROME; DISEASE COURSE; ENDOCRINE TUMOR; FEMALE; GASTRECTOMY; GASTRINOMA; HUMAN; LIVER METASTASIS; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; PARANEOPLASTIC SYNDROME; POSTOPERATIVE COMPLICATION; PROGNOSIS; STOMACH ACID; SURGICAL MORTALITY; TUMOR LOCALIZATION; TUMOR VOLUME; ULCER HEALING; ZOLLINGER ELLISON SYNDROME;

ADULT; AGE DISTRIBUTION; CUSHING SYNDROME; DISEASE PROGRESSION; FEMALE; FRANCE; GASTRINOMA; HUMANS; INCIDENCE; LIVER NEOPLASMS; LYMPHATIC METASTASIS; MALE; MIDDLE AGED; MULTIPLE ENDOCRINE NEOPLASIA TYPE 1; PANCREATIC NEOPLASMS; RISK FACTORS; SEX DISTRIBUTION; SURVIVAL RATE; ZOLLINGER-ELLISON SYNDROME;

EID: 0032721913     PISSN: 11258055     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (28)

1. Norton JA. Neuroendocrine tumors of the pancreas and duodenum. Curr Probl Surg 1994;31:81-156.
2. Capella C, La Rosa S, Solcia E. Criteria for malignancy in pancreatic tumors. Endocrine Pathology 1997;8;87-90.
3. Zayene A, Cadiot G, Vuagnat A, Bonnaud G, Mignon M. Survival factors in patients with endocrine liver metastases. Gastroenterology 1997;112:A496.
4. Sutliff VE, Doppman JL, Gibril F, Venzon DJ, Fang Y, Serrano J, et al. Growth of newly diagnosed untreated metastatic gastrinomas and predictors of growth pattern. J Clin Oncol 1997;15:2420-31.
5. Mignon M, Ruszniewski Ph, Haffar S, Rigaud D, René E, Bonfils S. Current approach to the management of tumoral process in patients with gatrinoma. World J Surg 1986;10:703-10.
6. Vallot Th., Mignon M, Mazure R, Bonfils S. Evaluation of antisecretory drug therapy of Zollinger-Ellison syndrome using 24-hour pH-monitoring. Dig Dis Sci 1983;28:577-84.
7. Metz DC, Jensen RT. Advances in gastric antisecretory therapy in Zollinger-Ellison syndrome. In: Mignon M, Jensen RT, editors. Endocrine Tumors of the Pancreas. Recent Advances in Research and Management. Basel: Karger. Front Gastrointest Res 1995;23:240-57.
8. Bonfils S, Landor JH, Mignon M, Hervoir P. Results of surgical management in 92 consecutive patients with Zollinger-Ellison syndrome. Ann Surg 1981;194:692-7.
9. Mignon M, Ruszniewski Ph, Podevin Ph, Sabbagh L, Cadiot G, Rigaud D, et al. Current approach to the management of gastrinoma and insulinoma in adults with multiple endocrine neoplasia type I. World J Surg 1993;17:489-97.
10. Cadiot G, Houillier P, Allouch A, Paillard M, Mignon M, GRESZE. Interest of the oral calcium tolerance test in the early diagnosis of primary hyperparathyroidism and multiple endocrine neoplasia type 1 in patients with the Zollinger-Ellsion syndrome. Gut 1996;39:273-8.
11. Eriksson B, Arnberg H, Lindgren PG, Lörelius LE, Magnusson A, Lundqvist G, et al. Neuroendocrine pancreatic tumors: clinical presentation, biochemical and histopathological findings in 84 patients. J Intern Med 1990;228:103-13.
12. Mignon M, Cadiot G, Rigaud D, Ruszniewski Ph, Jaïs Ph, Lehy T, et al. Management of islet cell tumors in patients with multiple endocrine neoplasia type I. In: Mignon M, Jensen RT, editors. Endocrine tumors of the pancreas. Recent advances and management. Basel: Karger; Front Gastrointest Res 1995;23:342-59.
13. Weber HC, Venzon DJ, Lin JT, Fishbein VA, Orbuch M, Strader DB, et al. Determinants of metastatic rate and survival in patients with Zollinger-Ellison syndrome: a prospective long-term study. Gastroenterology 1995;108:1637-49.
14. Cadiot G, Doukhan I, Vuagnat A, Murat A, Bonnaud G, Ruszniewski P, et al. Prognostic factors in patients with Zollinger-Ellison syndrome and multiple endocrine neoplasia type 1: a French multicentric study in 71 patients. Gastroenterology 1997;112:A431.
15. Howard TJ, Sawicki MP, Stabile BE, Watt PC, Passaro E Jr. Biologic behaviour of sporadic gastrinoma located to the right and left of the superior mesenteric artery. Am J Surg 1993;165;101-6.
16. Ellison EC. Forty-year appraisal of gastrinoma. Back to the future. Ann Surg 1995;222:511-24.
17. Fraker DL, Norton JA, Alexander RH, Venzon DJ, Jensen RT. Surgery in Zollinger-Ellison syndrome alters the natural history of gastrinoma. Ann Surg 1994;220:320-30.
18. Norton JA, Doppman JL, Jensen RT. Curative resection in Zollinger-Ellison syndrome: results of a 10-year prospective study. Ann Surg 1992;215:8-18.
19. Mignon M, Ruszniewski Ph, Hochlaf S, Sobhani I, Cadiot G, Legmann P, et al. Do endocrine liver metastases have intrinsic evolutive features helping decision making for liver transplantation? Gastroenterology 1991;100:A290.
20. Barton JC, Hirschowitz BI, Maton PN, Jensen RT. Bone metastases in malignant gastrinoma. Gastroenterology 1986;91:1179-85.
21. Cadiot G, Bonnaud G, Lebtahi R, Sarda L, Ruszniewski P, Le Guludec D, et al. Usefulness of somatostatin receptor scintigraphy in the management of patients with Zollinger-Ellison syndrome. Gut 1997;41:107-14.
22. Norton JA. Treatment of islet cell tumors with special emphasis on operative ultrasound. In: Mignon M, Jensen RT, editors. Endocrine tumors of the pancreas. Recent advances and management. Basel: Karger; Front Gastrointest Res 1995;23:309-32.
23. Lehy T, Cadiot G, Mignon M, Ruszniewski Ph, Bonfils S. Influence of multiple endocrine neoplasia type I on gastric endocrine cells in patients with the Zollinger-Ellison syndrome. Gut 1992;33:1275-9.
24. Krishnmurthy S, Terminini B, Jensen RT, Dayal Y. Gastric endocrine cell status in familial and sporadic Zollinger-Ellison syndrome. Mod Pathol 1997;9:59A.
25. Cadiot G, Laurent-Puig P, Thuille B, Lehy T, Mignon M, Olschwang S. Is the multiple endocrine neoplasia type I gene a suppressor for fundic argyrophil tumors in the Zollinger-Ellison syndrome? Gastroenterology 1993;105:579-82.
26. Debelenko LV, Emmert-Buck MR, Zhuang Z, Epshteyn E, Moskaluk CA, Jensen RT, et al. The multiple endocrine neoplasia type I gene locus is involved in the pathogenesis of type II gastric carcinoids. Gastroenterology 1997;113:773-81.
27. Cadiot G, Cattan D, Mignon M. Diagnosis and treatment of ECL-cell tumors. Yale J Biol Med 1999 (in press).
28. Wiedenmann B, Jensen RT, Mignon M, Modlin I, Skogseid B, Doherty G, et al. Preoperative diagnosis and surgical management of neuro-endocrine gastroenteropancreatic tumors. World J Surg 1998;22:309-18.